Sarepta Therapeutics plans to ask the U.S. Food and Drug Administration (FDA) to grant accelerated approval to the company’s…
Articles by Marisa Wexler, MS
The first participant has been dosed in the Phase 3 REACH clinical trial testing the safety and effectiveness of…
Pliant Therapeutics said it plans to ask the U.S. Food and Drug Administration (FDA) for permission to begin clinical testing…
The experimental oral therapy EDG-5506 has been generally well-tolerated and lowered markers of muscle damage among men with Becker…
The Muscular Dystrophy Association (MDA) is hosting a one-day games streaming fundraiser, dubbed “MDA Rivals,” this Saturday, June 18.
Reduced heart function is associated with a higher rate of mortality among people with Duchenne muscular dystrophy (DMD), a…
Treatment with glucocorticoids and heart medicines are key factors in determining the prognosis of Duchenne muscular dystrophy (DMD), according…
Despite broad initiatives seeking improvements, the time it takes an individual with Duchenne muscular dystrophy (DMD) to get a…
Treatment with the breast cancer medicine tamoxifen improved the functionality and survival of heart muscle cells in a cellular model…
The Spectrum Health Helen DeVos Children’s Hospital (HDVCH) in Michigan has been recognized as providing the highest quality of care…